Literature DB >> 22287019

Maintenance of rat hepatocytes under inflammation by coculture with human orbital fat-derived stem cells.

Xia Chen1, Shichang Zhang, Tao Liu, Yong Liu, Yingjie Wang.   

Abstract

Preservation of hepatocyte functions in vitro will undoubtedly help the management of acute liver failure. The coculture system may be able to prevent functional decline of hepatocytes. It has already been shown that hepatocytes, when cocultured with bone marrow mesenchymal stem cells, could undergo long-term culture in vitro without loss of functions. In this study, human orbital fat-derived stem cells were isolated and cocultured with rat hepatocytes. When treated with serum from an acute liver failure patient, rat hepatocyte monoculture showed reduction of cell viability and loss of liver-specific functions. However, rat hepatocytes in the coculture system were still able to secret albumin and synthesize urea. IL-6 was significantly elevated in the coculture of rat hepatocyte with orbital fat-derived stem cells, and it might be the key immunoregulator which protects rat hepatocytes against inflammation. Our data confirmed that orbital fat-derived stem cells, or other adipose tissue-derived stem cells, are an ideal candidate to support rat hepatocyte functions in vitro.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22287019      PMCID: PMC6275911          DOI: 10.2478/s11658-012-0004-9

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  29 in total

1.  Effects of bone marrow stromal cells on the structural and functional polarity of primary rat hepatocytes.

Authors:  Toru Mizuguchi; Kaia Palm; Thomas Hui; Takeshi Aoki; Yohichi Mochizuki; Toshihiro Mitaka; Achilles A Demetriou; Jacek Rozga
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-02       Impact factor: 2.416

Review 2.  Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures.

Authors:  Greetje Elaut; Tom Henkens; Peggy Papeleu; Sarah Snykers; Mathieu Vinken; Tamara Vanhaecke; Vera Rogiers
Journal:  Curr Drug Metab       Date:  2006-08       Impact factor: 3.731

Review 3.  Functional hepatocyte culture and its application to cell therapies.

Authors:  Kimiaki Tanaka; Alejandro Soto-Gutierrez; Nalu Navarro-Alvarez; Jorge David Rivas-Carrillo; Hee-Sook Jun; Naoya Kobayashi
Journal:  Cell Transplant       Date:  2006       Impact factor: 4.064

Review 4.  Stem cells for hepatic regeneration: the role of adipose tissue derived mesenchymal stem cells.

Authors:  Tetsuya Ishikawa; Agnieszka Banas; Keitaro Hagiwara; Hideki Iwaguro; Takahiro Ochiya
Journal:  Curr Stem Cell Res Ther       Date:  2010-06       Impact factor: 3.828

5.  Multilineage cells from human adipose tissue: implications for cell-based therapies.

Authors:  P A Zuk; M Zhu; H Mizuno; J Huang; J W Futrell; A J Katz; P Benhaim; H P Lorenz; M H Hedrick
Journal:  Tissue Eng       Date:  2001-04

Review 6.  Human hepatocyte transplantation: current experience and future challenges.

Authors:  Anil Dhawan; Juliana Puppi; Robin D Hughes; Ragai R Mitry
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

7.  Role of heparin on TNF-alpha and IL-6 levels in liver regeneration after partial hepatic resection.

Authors:  H Yuceturk; M C Yagmurdur; G Gur; M Demirbilek; B Bilezikci; M Turan; H Karakayali; M Haberal
Journal:  Eur Surg Res       Date:  2007-04-13       Impact factor: 1.745

Review 8.  Liver support devices.

Authors:  Jason Phua; Kang Hoe Lee
Journal:  Curr Opin Crit Care       Date:  2008-04       Impact factor: 3.687

9.  Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure.

Authors:  Hiroshi Yagi; Biju Parekkadan; Kazuhiro Suganuma; Alejandro Soto-Gutierrez; Ronald G Tompkins; Arno W Tilles; Martin L Yarmush
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

Review 10.  Acute liver failure: mechanisms of immune-mediated liver injury.

Authors:  Zeguang Wu; Meifang Han; Tao Chen; Weiming Yan; Qin Ning
Journal:  Liver Int       Date:  2010-05-20       Impact factor: 5.828

View more
  6 in total

1.  Co-culture system of hepatocytes and endothelial cells: two in vitro approaches for enhancing liver-specific functions of hepatocytes.

Authors:  Gaoxiong Wang; Youshi Zheng; Yingchao Wang; Zhixiong Cai; Naishun Liao; Jingfeng Liu; Wenmin Zhang
Journal:  Cytotechnology       Date:  2018-04-19       Impact factor: 2.058

2.  Alkaline phosphatase expression/activity and multilineage differentiation potential are the differences between fibroblasts and orbital fat-derived stem cells--a study in animal serum-free culture conditions.

Authors:  Thaís Maria da Mata Martins; Ana Cláudia Chagas de Paula; Dawidson Assis Gomes; Alfredo Miranda Goes
Journal:  Stem Cell Rev Rep       Date:  2014-10       Impact factor: 5.739

3.  Rodent animal models for surrogate analysis of cell therapy in acute liver failure.

Authors:  Bruno Christ; Sandra Brückner
Journal:  Front Physiol       Date:  2012-04-02       Impact factor: 4.566

4.  Caveolin-1 is essential in the differentiation of human adipose-derived stem cells into hepatocyte-like cells via an MAPK pathway-dependent mechanism.

Authors:  Xin Guan; Nan Wang; Fenggong Cui; Yang Liu; Peng Liu; Jingyuan Zhao; Chao Han; Xiaoyan Li; Zhiqian Leng; Ying Li; Xiaofei Ji; Wei Zou; Jing Liu
Journal:  Mol Med Rep       Date:  2015-12-30       Impact factor: 2.952

5.  Conditioned Media Derived from Human Adipose Tissue Mesenchymal Stromal Cells Improves Primary Hepatocyte Maintenance.

Authors:  Zahra Azhdari Tafti; Mehdi Mahmoodi; Mohamad Reza Hajizadeh; Vahid Ezzatizadeh; Hossein Baharvand; Massoud Vosough; Abbas Piryaei
Journal:  Cell J       Date:  2018-05-15       Impact factor: 2.479

6.  The expression of the eotaxins IL-6 and CXCL8 in human epithelial cells from various levels of the respiratory tract.

Authors:  Magdalena Paplińska-Goryca; Patrycja Nejman-Gryz; Ryszarda Chazan; Hanna Grubek-Jaworska
Journal:  Cell Mol Biol Lett       Date:  2013-12-02       Impact factor: 5.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.